Diversified Enterprises’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$432K Sell
2,901
-158
-5% -$22.2K 0.02% 292
2026
Q2
$386K Sell
3,059
-126
-4% -$16.6K 0.02% 288
2026
Q1
$444K Sell
3,185
-4
-0.1% -$560 0.02% 257
2025
Q4
$391K Buy
+3,189
New +$388K 0.02% 255

Other funds holding GILD

Diversified Enterprises's GILD Position: Q3 2026 in Review

Diversified Enterprises reduced its Gilead Sciences (GILD) stake by 5.2% in Q3 2026, selling an estimated $22.2K and leaving 2,901 shares worth $432K. The position accounts for 0.02% of the portfolio, ranked #292.

Diversified Enterprises first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. The position peaked at $444K in Q1 2026. 2,341 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Diversified Enterprises held 2,901 shares of Gilead Sciences worth $432K as of Q3 2026.
  • Diversified Enterprises sold 158 Gilead Sciences shares in Q3 2026, an estimated $22.2K.
  • Gilead Sciences made up 0.02% of Diversified Enterprises's portfolio in Q3 2026, its #292 holding.
  • Diversified Enterprises first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
  • Diversified Enterprises's Gilead Sciences position peaked at $444K in Q1 2026.
  • 2,341 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Diversified Enterprises's 13F filing for Q3 2026, filed 19 Oct 2026.